Literature DB >> 7487206

Preoperative chemotherapy: where do we go from here?

T J Eberlein.   

Abstract

Mesh：

Year:  1995        PMID： 7487206      PMCID： PMC1234986          DOI： 10.1097/00000658-199311000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  9 in total

1.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.

Authors:  G Bonadonna; U Veronesi; C Brambilla; L Ferrari; A Luini; M Greco; C Bartoli; G Coopmans de Yoldi; R Zucali; F Rilke
Journal:  J Natl Cancer Inst       Date:  1990-10-03       Impact factor: 13.506

2.  Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB).

Authors:  C Jacquillat; F Baillet; M Weil; G Auclerc; M Housset; M Auclerc; M Sellami; A Jindani; L Thill; C Soubrane
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

3.  Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size.

Authors:  T J Eberlein; J L Connolly; S J Schnitt; A Recht; R T Osteen; J R Harris
Journal:  Arch Surg       Date:  1990-06

4.  Primary medical (neo-adjuvant) chemotherapy for operable breast cancer.

Authors:  I E Smith; A L Jones; M E O'Brien; J A McKinna; N Sacks; M Baum
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

5.  Multimodal treatment of locoregionally advanced breast cancer.

Authors:  G N Hortobagyi; G R Blumenschein; W Spanos; E D Montague; A U Buzdar; H Y Yap; F Schell
Journal:  Cancer       Date:  1983-03-01       Impact factor: 6.860

6.  Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

Authors:  G E Peoples; P S Goedegebuure; R Smith; D C Linehan; I Yoshino; T J Eberlein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

7.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

Authors:  B Fisher; M Bauer; R Margolese; R Poisson; Y Pilch; C Redmond; E Fisher; N Wolmark; M Deutsch; E Montague
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

8.  Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

Authors:  T J Powles; T F Hickish; A Makris; S E Ashley; M E O'Brien; V A Tidy; S Casey; A G Nash; N Sacks; D Cosgrove
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

9.  Conservation surgery after primary chemotherapy in large carcinomas of the breast.

Authors:  U Veronesi; G Bonadonna; S Zurrida; V Galimberti; M Greco; C Brambilla; A Luini; S Andreola; F Rilke; R Raselli
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.